Cara Therapeutics, Inc. (CARA) |
|---|
| $4.35 52 Week Low | $15.89 2017-04-28 15:46:58 MDT | $20.9 52 Week High |
| Healthcare Sector | Biotechnology Industry |
| Nasdaq Stock Exchange | United States Country |
| Market Cap: | $527,320,000 | Small Cap (Between $200M and $2B) |
| Analyst Recommendation: | 1.6 | Analysts say: Buy+. (1=Strong Buy, 5=Strong Sell) |
| Beta: | 2.86 | Higher Volatility Stock (beta over 1). Stock will go up more when the market goes up, and go down more when the market goes down. Beta of 1 means stock would match the S&P 500 Index. |
ForwardPE: Unknown | 5 Yr Est Growth: Unknown | Yield: 0.00% |
PEG-Y Ratio: N/A | Unknown PEG-Y ratio |
% Above 50 DayMA: -7.78% | % Above 200 DayMA: 26.71% |
CARA Performance 52 Weeks: 160.73% | S&P 500 Performance 52 Weeks: 12.50% |
Mixed Trend. Short Term trend is down, but longer term trend is up. There is hope because 50 Day MA is still above 200 Day MA. Stock is closer to 52 Week High than 52 Week Low. | CARA outperforming S&P 500 by 148.23% the last 52 Weeks. |
Price To Book: 8.9 | OK Value. Low Price to Book means better value. A P/B value of 5 or less is great. |
EV to EBITDA: -6.9 | Unknown EV to EBITDA ratio |
| Field | Value | Average | Comments |
|---|---|---|---|
| % Held By Insiders | 29.45% | 17.28% | Held by greater than average Insiders. Insiders can sway stock price. Watch insider buying and selling. |
| % Held By Institutions | 45.70% | 62.07% | Institutional percentage lower than average. Institutions may not have conviction in stock. Or is this a chance for institutions to invest more and boost price? |
| Short % Of Float | N/A | 07.02% | Unknown. |
| Debt to Equity | N/A | 1.08 | Unknown. |
| Profit Margin % | N/A | -00.18% | Unknown. |
| Operating Margin % | -67.00% | -05.28% | Operating Margin less than average percent. Stock can do better than this? |
| Return on Equity % | -73.55% | -08.79% | Return on Equity less than average percent. Stock can do better than this? |
| Return on Assets % | -41.78% | -01.29% | Return on Assets less than average percent. Stock can do better than this? |
| Revenue Per Employee | $2,529.41 | $883,096.70 | Less than average Revenue Per Employee. This stock (or industry) might not be as efficient as others? Each industry might have a different standard. |
| Price to Cash | 7.46 | 5.52 | Higher than average Price to Cash. Meaning that the company has a lower percentage of cash as a percent of price. Cash can be good to cushion company during hard times, and as a potential source for buyouts or investments. However, some activists want the cash to be used by a company to buy its own stock, or to increase their dividend, or to invest the money. |
| CPEGY Ratio | N/A | 2.26 | Unknown. |
PROS:
| CONS:
|